HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $508,937 | -36.3% | 13,323 | -39.8% | 0.00% | -75.0% |
| Q2 2023 | $798,516 | -83.8% | 22,138 | -82.9% | 0.00% | -60.0% |
| Q1 2023 | $4,942,053 | -42.8% | 129,407 | -14.7% | 0.01% | -47.4% |
| Q4 2022 | $8,633,608 | +33.5% | 151,733 | -7.2% | 0.02% | +11.8% |
| Q3 2022 | $6,465,000 | -8.0% | 163,494 | +2.3% | 0.02% | -5.6% |
| Q2 2022 | $7,029,000 | -14.8% | 159,742 | -22.8% | 0.02% | 0.0% |
| Q1 2022 | $8,253,000 | +0.9% | 206,950 | +1.7% | 0.02% | 0.0% |
| Q4 2021 | $8,181,000 | +22.4% | 203,457 | +23.9% | 0.02% | +12.5% |
| Q3 2021 | $6,683,000 | -20.5% | 164,272 | -11.2% | 0.02% | -27.3% |
| Q2 2021 | $8,405,000 | +120.3% | 185,082 | +102.2% | 0.02% | +83.3% |
| Q1 2021 | $3,815,000 | +0.8% | 91,520 | +3.3% | 0.01% | 0.0% |
| Q4 2020 | $3,785,000 | +78.5% | 88,624 | +9.8% | 0.01% | +50.0% |
| Q3 2020 | $2,121,000 | -1.7% | 80,707 | +0.3% | 0.01% | -20.0% |
| Q2 2020 | $2,157,000 | +176.2% | 80,451 | +85.2% | 0.01% | +150.0% |
| Q1 2020 | $781,000 | +1.4% | 43,437 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $770,000 | +16.8% | 43,437 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $659,000 | -8.7% | 42,467 | +1.0% | 0.00% | -25.0% |
| Q2 2019 | $722,000 | +6.8% | 42,036 | +0.1% | 0.00% | 0.0% |
| Q1 2019 | $676,000 | +10.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $614,000 | -21.0% | 42,000 | -1.7% | 0.00% | 0.0% |
| Q3 2018 | $777,000 | +7.8% | 42,736 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $721,000 | -18.3% | 42,736 | -5.1% | 0.00% | -33.3% |
| Q1 2018 | $882,000 | -3.3% | 45,011 | +0.0% | 0.01% | 0.0% |
| Q4 2017 | $912,000 | +24.9% | 45,000 | +7.1% | 0.01% | +20.0% |
| Q3 2017 | $730,000 | +35.7% | 42,000 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $538,000 | -1.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $544,000 | +31.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $415,000 | -18.1% | 42,000 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $507,000 | +40.1% | 42,000 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $362,000 | -9.0% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $398,000 | -57.5% | 42,000 | -22.3% | 0.00% | -60.0% |
| Q4 2015 | $936,000 | +62.2% | 54,025 | +25.6% | 0.01% | +42.9% |
| Q3 2015 | $577,000 | -39.1% | 43,000 | +2.4% | 0.01% | -36.4% |
| Q2 2015 | $948,000 | +58.0% | 42,005 | -0.1% | 0.01% | +57.1% |
| Q1 2015 | $600,000 | +43.9% | 42,050 | -2.8% | 0.01% | +40.0% |
| Q4 2014 | $417,000 | +9.2% | 43,250 | +3.0% | 0.01% | 0.0% |
| Q3 2014 | $382,000 | -8.0% | 42,000 | 0.0% | 0.01% | -28.6% |
| Q2 2014 | $415,000 | -22.3% | 42,000 | 0.0% | 0.01% | -30.0% |
| Q1 2014 | $534,000 | -15.2% | 42,000 | 0.0% | 0.01% | -23.1% |
| Q4 2013 | $630,000 | +35.8% | 42,000 | 0.0% | 0.01% | +18.2% |
| Q3 2013 | $464,000 | +38.9% | 42,000 | 0.0% | 0.01% | +37.5% |
| Q2 2013 | $334,000 | – | 42,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |